These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 28075176)

  • 1. The ADAPP trial: a two-year longitudinal multidisciplinary intervention study for prostate cancer frail patients on androgen deprivation associated to curative radiotherapy.
    Mareschal J; Weber K; Rigoli P; Biason E; Frambati L; Gotteland C; Zilli T; Pichard C; Miralbell R
    Acta Oncol; 2017 Apr; 56(4):569-574. PubMed ID: 28075176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostate cancer and androgen deprivation: benefits of psychological counseling].
    Frambati L; Weber K; Canuto A; Miralbell R; Zilli T; Pichard C; Joly C; Voison N; Santos JF
    Rev Med Suisse; 2013 Feb; 9(373):369-70, 372-3. PubMed ID: 23477070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Male coping through a long-term cancer trajectory. Secondary outcomes from a RTC examining the effect of a multidisciplinary rehabilitation program (RePCa) among radiated men with prostate cancer.
    Dieperink KB; Johansen C; Hansen S; Wagner L; K Andersen K; Minet LR; Hansen O
    Acta Oncol; 2017 Feb; 56(2):254-261. PubMed ID: 28093012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.
    Zapatero A; Guerrero A; Maldonado X; Alvarez A; Gonzalez San Segundo C; Cabeza Rodríguez MA; Macias V; Pedro Olive A; Casas F; Boladeras A; de Vidales CM; Vazquez de la Torre ML; Villà S; Perez de la Haza A; Calvo FA
    Lancet Oncol; 2015 Mar; 16(3):320-7. PubMed ID: 25702876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term impact of androgen-deprivation therapy on physical function and quality of life.
    Alibhai SM; Breunis H; Timilshina N; Naglie G; Tannock I; Krahn M; Warde P; Fleshner NE; Canning SD; Tomlinson G
    Cancer; 2015 Jul; 121(14):2350-7. PubMed ID: 25809861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue and other adverse effects in men treated by pelvic radiation and long-term androgen deprivation for locally advanced prostate cancer.
    Lilleby W; Stensvold A; Dahl AA
    Acta Oncol; 2016 Jul; 55(7):807-13. PubMed ID: 26959297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy.
    Chipperfield K; Fletcher J; Millar J; Brooker J; Smith R; Frydenberg M; Burney S
    Psychooncology; 2013 Oct; 22(10):2169-76. PubMed ID: 23483679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial.
    Denham JW; Wilcox C; Joseph D; Spry NA; Lamb DS; Tai KH; Matthews J; Atkinson C; Turner S; Christie D; Gogna NK; Kenny L; Duchesne G; Delahunt B; McElduff P
    Lancet Oncol; 2012 Dec; 13(12):1260-70. PubMed ID: 23151431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study.
    Hansen PA; Dechet CB; Porucznik CA; LaStayo PC
    PM R; 2009 Nov; 1(11):1019-24. PubMed ID: 19942188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term health-related quality of life after primary treatment for localized prostate cancer: results from the CaPSURE registry.
    Punnen S; Cowan JE; Chan JM; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Oct; 68(4):600-8. PubMed ID: 25242555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A longitudinal study of coping strategies in men receiving radiotherapy and neo-adjuvant androgen deprivation for prostate cancer: a quantitative and qualitative study.
    McSorley O; McCaughan E; Prue G; Parahoo K; Bunting B; O'Sullivan J
    J Adv Nurs; 2014 Mar; 70(3):625-38. PubMed ID: 23919321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of androgen deprivation therapy on mental and emotional well-being in men with prostate cancer: analysis from the CaPSURE™ registry.
    Cary KC; Singla N; Cowan JE; Carroll PR; Cooperberg MR
    J Urol; 2014 Apr; 191(4):964-70. PubMed ID: 24184370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
    Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
    Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deprivation therapy for prostate cancer: effects on hand function.
    Soyupek F; Soyupek S; Perk H; Ozorak A
    Urol Oncol; 2008; 26(2):141-6. PubMed ID: 18312932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance training and reduction of treatment side effects in prostate cancer patients.
    Galvão DA; Nosaka K; Taaffe DR; Spry N; Kristjanson LJ; McGuigan MR; Suzuki K; Yamaya K; Newton RU
    Med Sci Sports Exerc; 2006 Dec; 38(12):2045-52. PubMed ID: 17146309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age on quality-of-life outcomes after treatment for localized prostate cancer.
    Hampson LA; Cowan JE; Zhao S; Carroll PR; Cooperberg MR
    Eur Urol; 2015 Sep; 68(3):480-6. PubMed ID: 25656807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.
    Nilsen TS; Raastad T; Skovlund E; Courneya KS; Langberg CW; Lilleby W; Fosså SD; Thorsen L
    Acta Oncol; 2015 Nov; 54(10):1805-13. PubMed ID: 25927504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study.
    Sajid S; Dale W; Mustian K; Kotwal A; Heckler C; Porto M; Fung C; Mohile SG
    J Geriatr Oncol; 2016 Mar; 7(2):71-80. PubMed ID: 26916611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease.
    Keane FK; Chen MH; Zhang D; Moran BJ; Braccioforte MH; D'Amico AV
    Cancer; 2015 Aug; 121(16):2713-9. PubMed ID: 25925789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.